|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Inducement expense, net | |||||
| Change in fair value of investment option liability | |||||
| Change in fair value of derivative liability | |||||
| Interest (expense) income, net | |||||
| Total other income | |||||
| Net loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Less deemed dividend on inducement of warrants | |||||
| Less deemed dividends attributable to accretion of embedded derivative at redemption value | |||||
| Net loss attributable to shareholders | |||||
| Other comprehensive income (loss) | |||||
| Foreign currency translation | |||||
| Comprehensive loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average shares outstanding, basic | |||||
| Weighted average shares outstanding, diluted | |||||
Loading...